359 related articles for article (PubMed ID: 29693976)
1. Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis.
Abdel-Hafiz SM; Hamdy HE; Khorshed FM; Aboushousha TS; Safwat G; Saber MA; Seleem M; Soliman AH
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1021-1027. PubMed ID: 29693976
[TBL] [Abstract][Full Text] [Related]
2. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.
Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D
Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of plasma osteopontin level in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
El-Din Bessa SS; Elwan NM; Suliman GA; El-Shourbagy SH
Arch Med Res; 2010 Oct; 41(7):541-7. PubMed ID: 21167394
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C
PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
[TBL] [Abstract][Full Text] [Related]
9. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
[TBL] [Abstract][Full Text] [Related]
10. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX
Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407
[TBL] [Abstract][Full Text] [Related]
11. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.
Duarte-Salles T; Misra S; Stepien M; Plymoth A; Muller D; Overvad K; Olsen A; Tjønneland A; Baglietto L; Severi G; Boutron-Ruault MC; Turzanski-Fortner R; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Bamia C; Pala V; Palli D; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez-Cantalejo E; Ardanaz E; Gavrila D; Dorronsoro M; Werner M; Hemmingsson O; Ohlsson B; Sjöberg K; Wareham NJ; Khaw KT; Bradbury KE; Gunter MJ; Cross AJ; Riboli E; Jenab M; Hainaut P; Beretta L
Cancer Prev Res (Phila); 2016 Sep; 9(9):758-65. PubMed ID: 27339170
[TBL] [Abstract][Full Text] [Related]
12. Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Shang S; Plymoth A; Ge S; Feng Z; Rosen HR; Sangrajrang S; Hainaut P; Marrero JA; Beretta L
Hepatology; 2012 Feb; 55(2):483-90. PubMed ID: 21953299
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
[TBL] [Abstract][Full Text] [Related]
14. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.
Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y
J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.
Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ
Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515
[TBL] [Abstract][Full Text] [Related]
16. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
Li J; Chen X; Dai M; Huang S; Chen J; Dai S
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):543-553. PubMed ID: 28291627
[TBL] [Abstract][Full Text] [Related]
18. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
19. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
[TBL] [Abstract][Full Text] [Related]
20. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
